Not applicableActive Not RecruitingNCT05674422
What this trial is testing
GEMCAD-REVEAL STUDY - Circulating Tumor DNA as a Predictor of Relapse in Patients With Locally Advanced Rectal Cancer.
Who this might be right for
Patients With Locally Advanced Rectal Cancer
Grupo Espanol Multidisciplinario del Cancer Digestivo 120